Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | ATM | Q13315 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | MPI | P34949 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL21391655 | 0.97 | ATM (0.50) | MAPTATMALDH1A1MCL1CES2 | |
| SCHEMBL485498 | 0.85 | MAPT (0.45) | MAPTATMALDH1A1MCL1CES2 | |
| SCHEMBL19413742 | 0.83 | MAPT (0.43) | MAPTATMALDH1A1MCL1CES2 | |
| SCHEMBL9455658 | 0.82 | ATM (0.39) | MAPTATMALDH1A1MCL1CES2 | |
| SCHEMBL359232 | 0.82 | ATM (0.52) | MAPTATMALDH1A1MCL1CES2 | |
| SCHEMBL9841858 | 0.79 | ALDH1A1 (0.41) | MAPTATMALDH1A1MCL1CES2 | |
| SCHEMBL8934766 | 0.78 | CA2 (0.61) | MAPTATMALDH1A1MCL1CES2 | |
| SCHEMBL14081321 | 0.78 | ATM (0.48) | MAPTATMALDH1A1MCL1CES2 | |
| SCHEMBL1252912 | 0.78 | ATM (0.48) | MAPTATMALDH1A1MCL1CES2 | |
| SCHEMBL16308964 | 0.78 | ATM (0.48) | MAPTATMALDH1A1MCL1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1523 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731596-A1 | NITROGEN STABILIZER COMPOSITIONS AND RELATED METHODS | Verdesian Life Sciences U.S., LLC (US) | 2026-04-29 | — | — | EP | claimed |
| US-20260078233-A1 | ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING HYDROCARBON CHAINS | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2026-03-19 | — | — | US | claimed |
| US-20250347684-A1 | METABOLIC BIOMARKERS IN BLOOD SERUM FOR DIAGNOSIS OF ALZHEIMER'S DISEASE | UNIV TEXAS (US) | 2025-11-13 | — | — | US | claimed |
| US-20250262169-A1 | METHODS OF TREATING COENZYME Q10 DEFICIENCY | THLIVERIS, ANDREW T. | 2025-08-21 | — | — | US | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| EP-4569018-A1 | ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING HYDROCARBON CHAINS | Teknologian Tutkimuskeskus VTT OY (FI) | 2025-06-18 | — | — | EP | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| WO-2024263561-A1 | NITROGEN STABILIZER COMPOSITIONS AND RELATED METHODS | VERDESIAN LIFE SCIENCES U.S., LLC (US) | 2024-12-26 | — | — | WO | claimed |
| CN-118834546-A | Electrochromic device and preparation method thereof | 吉林大学 | 2024-10-25 | — | — | CN | claimed |
| CN-109860957-B | Lithium air battery | 松下知识产权经营株式会社 | 2024-06-21 | — | — | CN | claimed |
| EP-0540840-A1 | Stabilized 1,1-dichloro, 1-fluoro ethane | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1993-05-12 | — | — | EP | claimed |
| US-5169996-A | Stabilized 141b | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1992-12-08 | — | — | US | claimed |
| CN-1019262-B | ROT-PROOF ANTIOXIDATION AGENT FOR MINK FEED | NUTRITION SOURCE INST BEIJING (CN) | 1992-12-02 | — | — | CN | claimed |
| CN-1059454-A | LONG-LASTING FUNGICIDE FOR COMPOSITE FEED | JIANG SHILEI (CN) | 1992-03-18 | — | — | CN | claimed |
| US-4988754-A | Linear alternating copolymer of carbon monoxide, ethylene and an unsaturated olefin monomer with a stabilizing alkylated ben zoquinone | SHELL OIL COMPANY (US) | 1991-01-29 | — | — | US | claimed |
| CN-1043865-A | Rot-proof antioxidation agent for mink feed | NUTRITION SOURCE INST BEIJING (CN) | 1990-07-18 | — | — | CN | claimed |
| US-4888255-A | PREVENTION OF VOLTAGE DROP IN LITHIUM BATTERY | HITACHI MAXELL, LTD. (JP) | 1989-12-19 | — | — | US | claimed |
| EP-0296589-A2 | Non-aqueous electrochemical cell | Hitachi Maxell Ltd. (JP) | 1988-12-28 | — | — | EP | claimed |
| US-4220528-A | CONTACTING A GAS WITH A SOLUTION CONTAINING A HYDRAZINE, A QUINONE, AN ALKALI; CONTACTING THE DEOXYGENATED GAS WITH WATER | OTSUKA CHEMICAL CO., LTD. (JP) | 1980-09-02 | — | — | US | claimed |
| US-4053468-A | PROCESS FOR PREPARING 7-OXO CEPHALOSPORINS AND 6-OXO PENICILLINS | SMITHKLINE CORPORATION (US) | 1977-10-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250262169-A1 | METHODS OF TREATING COENZYME Q10 DEFICIENCY | NDUFB10, NDUFA10, NDUFB11 | MAPT 3300/4885ATM 2999/4885ALDH1A1 1016/4885 |
| US-20260078233-A1 | ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING HYDROCARBON CHAINS | PREP, CPSF1, CPSF7 | MAPT 3613/4885ATM 2457/4885ALDH1A1 2583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.